FDA PERMITS EMERGENCY USE OF COVID-19 DRUG BY ELI LILLY & CO

Highlights

• Bamlanivimab developed by Eli Lilly & Co was granted emergency use authorization (EUA) by the FDA based on trial data which showcased that a one-time infusion of the treatment was successful in reducing the need for hospitalization

• This drug from E...

TRIALS BEGIN FOR COVID ANTIBODY DRUG

Highlights:

• The National Institute of Health announced on Tuesday that the trials for the COVID antibody drug will begin.
• There are two trials called ACTIV-2 and ACTIV-3 for both considering the safety and efficacy of an antibody...